Eton Pharmaceuticals, Inc. (ETON)
31.05
+0.52
(+1.70%)
USD |
NASDAQ |
Jun 10, 11:20
Eton Pharmaceuticals EPS Diluted (Quarterly) : 0.0493 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Daré Bioscience, Inc. | -0.2066 |
| Tarsus Pharmaceuticals, Inc. | -0.1622 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.554M |
| Revenue (Quarterly) | 24.27M |
| Total Expenses (Quarterly) | 22.71M |
| Enterprise Value | 846.90M |
| Gross Profit Margin (Quarterly) | 60.72% |
| Profit Margin (Quarterly) | 6.40% |
| Earnings Yield | -0.23% |
| Operating Earnings Yield | 0.25% |
| Normalized Earnings Yield | -0.2071 |